Young Discusses New Requirements On Federally Funded Duke University Medical Researchers
March 26, 2018
Durham Herald Sun
Senior Counsel Torrey Young was quoted in a Durham Herald Sun article, “The feds are keeping a closer eye on Duke research grants. Why?” about the imposition of new National Institutes of Health requirements on university-based medical research in response to concerns about Duke’s handling of several recent research misconduct cases.
Young said the significance of the move is that the NIH, which funds tens of millions of dollars’ worth of medical research at Duke each year, seems worried about more than just a few individual bad actors.
“It’s a call for making sure the entire process is being overseen by the university, which is the ultimate recipient of the grant funds,” she said. “Historically, a lot of research misconduct cases have focused on the individual investigator. This is drawing more attention to institutional processes.”
Young said the significance of the move is that the NIH, which funds tens of millions of dollars’ worth of medical research at Duke each year, seems worried about more than just a few individual bad actors.
“It’s a call for making sure the entire process is being overseen by the university, which is the ultimate recipient of the grant funds,” she said. “Historically, a lot of research misconduct cases have focused on the individual investigator. This is drawing more attention to institutional processes.”
Related News
August 5, 2025
In the News
Aaron Maguregui on Health Data Sharing Plan – 'I would expect the FTC to be heavily involved'
Foley & Lardner LLP partner Aaron Maguregui addressed a new health care data sharing initiative announced by the federal government in the Bloomberg Law article, "Digital Data-Sharing Plan Tests Limits of Health Privacy Rules."
August 1, 2025
In the News
Aaron Maguregui Assesses HIPAA Challenges as AI Advances in Health Care
Foley & Lardner LLP partner Aaron Maguregui commented in the Medical Device Network article, "AI proliferation in healthcare shines light on HIPAA shortcomings," assessing the rise and accompanying risks of artificial intelligence in health care.
August 1, 2025
In the News
Louis Lehot Assesses Figma IPO
Foley & Lardner LLP partner Louis Lehot commented on a major technology initial public offering in the Business Insider article, "Lina Kahn is taking a victory lap over the Figma IPO."